The mRFP-GFP-LC3 transgenic mice were created by Dr F. Menzies under the jurisdiction of appropriate Home Office Project and Personal animal licenses and with local Ethics Committee approval, as previously reported in ref. 17.
For primary mRFP-GFP-LC3 mouse fibroblasts, transgenic mice were crossed with C57BL6 mice and pregnant females (E16.5 gestation) were sacrificed and embryos were harvested. The primary mRFP-GFP-LC3 mouse fibroblasts were grown in DMEM (D6546 Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, F7524 Sigma-Aldrich), 100 U ml−1 penicillin-streptomycin (P0781 Sigma-Aldrich), 2 mM L-glutamine (G7513 Sigma-Aldrich) at 37 °C and 5% CO2, humidified atmosphere.
Copyright and License information: The Author(s) ©2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.